TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31303542

Group type: EXPERIMENTAL
Intervention: Robotic surgical simulator (RoSS)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Laparoscopic simulator (LS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Unpracticed modality
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Practiced modality (LS or RoSS)
Number of subjects: 31
Study: 28865926

Group type: EXPERIMENTAL
Intervention: Hazard anticipation training (two classroom sessions with video clips of dangerous traffic situations)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (no training during the initial phase)
Number of subjects: 124
Study: 26265063

Group type: EXPERIMENTAL
Intervention: Amoxicillin (1 g) 1 h before surgery + 500 mg 8/8 h for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Amoxicillin (1 g) 1 h before surgery + placebo (identical appearance to G1) 8/8 h for 7 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo 1 h before surgery and 500 mg 8/8 h for 7 days
Number of subjects: 80
Study: 23322524

Group type: COMPARATOR
Intervention: FEC (6 cycles)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: FEC-D (3 cycles of FEC followed by 3 cycles of docetaxel)
Number of subjects: 657

Group type: COMPARATOR
Intervention: FEC
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: FEC-D
Number of subjects: 657
Study: 20848235

Group type: COMPARATOR
Intervention: Discontinued referrals
Number of subjects: 61931

Group type: COMPARATOR
Intervention: Unresolved referrals
Number of subjects: 61931

Group type: COMPARATOR
Intervention: Returned referrals to PCPs
Number of subjects: 61931

Group type: EXPERIMENTAL
Intervention: Follow-up actions
Number of subjects: 61931
Study: 19530321

Group type: EXPERIMENTAL
Intervention: 600 mg clopidogrel
Number of subjects: 95
Study: 17302696

Group type: EXPERIMENTAL
Intervention: Intracoronary enalaprilat (EN), 50 mug, administered immediately after reperfusion
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (PL) administered immediately after reperfusion
Number of subjects: 22
Study: 14757394

Group type: EXPERIMENTAL
Intervention: Pregnant patients with uncomplicated falciparum malaria
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-infected pregnant women
Number of subjects: 20
Study: 11691524

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 36

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 36
Study: 9330414

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 50 micrograms twice daily (b.i.d.)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Sodium cromoglycate (SCG) 20 mg four times daily (q.i.d.)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 122
Study: 7953445

Group type: EXPERIMENTAL
Intervention: Anterograde delivered cardioplegic solution (Group A, n = 19)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Retrograde delivered cardioplegic solution (Group B, n = 17)
Number of subjects: 36
Study: 6385797

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (n=33)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Continued chemotherapy (n=46)
Number of subjects: 111
Study: 31246894

Group type: EXPERIMENTAL
Intervention: Indapamide 1.5 mg sustained release/Amlodipine 5 mg SPC
Number of subjects: 465

Group type: COMPARATOR
Intervention: Amlodipine 5 mg/Valsartan 80 mg SPC
Number of subjects: 465
Study: 30379942

Group type: EXPERIMENTAL
Intervention: Teach-Back
Number of subjects: 637

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 637
Study: 27050256

Group type: EXPERIMENTAL
Intervention: Aronia-citrus juice (ACJ) intake
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Physical exercise
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Aronia-citrus juice (ACJ) intake and physical exercise
Number of subjects: 16
Study: 25043067

Group type: EXPERIMENTAL
Intervention: HELIOS completed biodegradable polymer SES
Number of subjects: 287

Group type: COMPARATOR
Intervention: PARTNER durable polymer SES
Number of subjects: 287
Study: 23198712

Group type: EXPERIMENTAL
Intervention: Automated telephone intervention for FOBT screening
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automated telephone intervention for patients aged ≥70 years
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group for patients aged ≥70 years
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automated telephone intervention for younger patients
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group for younger patients
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall cost-effectiveness
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness probability
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automated telephone intervention
Number of subjects: 100
Study: 20353434

Group type: EXPERIMENTAL
Intervention: Single tablet combination of sumatriptan succinate and naproxen sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18203072

Group type: EXPERIMENTAL
Intervention: Integrated monitoring of blood volume, blood pressure, heart rate, and bioimpedance during hemodialysis.
Number of subjects: 19
Study: 16409523

Group type: EXPERIMENTAL
Intervention: Avoiding blood sampling (ABS)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Using the drug on prescription (PD)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Over the counter (OTC)
Number of subjects: 56
Study: 15245937

Group type: EXPERIMENTAL
Intervention: Sacral nerve stimulation therapy
Number of subjects: 89

Group type: COMPARATOR
Intervention: Delayed implant group (Control)
Number of subjects: 89
Study: 10879416

Group type: EXPERIMENTAL
Intervention: 20-40 mg/day lovastatin
Number of subjects: 6605

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6605
Study: 9312536

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Cholelithiasis
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (no coexisting disorders)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus or cholelithiasis
Number of subjects: 143
Study: 1518259

Group type: EXPERIMENTAL
Intervention: Cranial irradiation (mandatory in patients with leukocyte count > 70,000/mm3 and initial CNS involvement, later abandoned)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cranial irradiation
Number of subjects: 210

Group type: COMPARATOR
Intervention: Non-irradiated
Number of subjects: 210
Study: 6472116

Group type: EXPERIMENTAL
Intervention: Diet A (360 kcal, 1.5 g egg protein per kg IBW, no carbohydrate)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Diet B (340 kcal, 0.8 g egg protein per kg IBW, 0.7 g carbohydrate per kg IBW)
Number of subjects: 11
Study: 31912474

Group type: EXPERIMENTAL
Intervention: diclofenac sodium 50 mg bid
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: tamsulosin 0.2 mg sid
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: combination of tamsulosin and diclofenac sodium
Number of subjects: 80

Group type: COMPARATOR
Intervention: placebo tid
Number of subjects: 80
Study: 30277539

Group type: EXPERIMENTAL
Intervention: Genetically predicted fasting insulin
Number of subjects: 182306

Group type: EXPERIMENTAL
Intervention: Genetically predicted 2-h glucose
Number of subjects: 182306

Group type: EXPERIMENTAL
Intervention: Genetically predicted BMI
Number of subjects: 182306

Group type: EXPERIMENTAL
Intervention: Genetically predicted WHRadj BMI
Number of subjects: 182306
Study: 28262473

Group type: EXPERIMENTAL
Intervention: Low-Dose-Rate Prostate Brachytherapy (LDR-PB) boost
Number of subjects: 398

Group type: COMPARATOR
Intervention: Dose-Escalated External Beam Radiation Therapy (DE-EBRT) boost
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Overall Survival
Number of subjects: 398
Study: 25884648

Group type: EXPERIMENTAL
Intervention: Mobile mindfulness training plus experience sampling
Number of subjects: 140

Group type: COMPARATOR
Intervention: Experience sampling-only (Control)
Number of subjects: 140
Study: 23611930

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin (100 mg 2 times a day for 3 days)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 20724299

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided radiofrequency ablation (RFA) of the great saphenous vein (GSV); n = 90
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard surgical treatment; n = 90
Number of subjects: 180
Study: 19785725

Group type: EXPERIMENTAL
Intervention: Intracoronary abciximab administration
Number of subjects: 530

Group type: COMPARATOR
Intervention: Intravenous abciximab administration
Number of subjects: 530
Study: 16400064

Group type: EXPERIMENTAL
Intervention: Mixed carotenoids (beta‐carotene, lutein, and lycopene; 4 mg each)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Beta‐carotene (12 mg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 14965157

Group type: EXPERIMENTAL
Intervention: Adverse drug event tracking calendar provided to the intervention group
Number of subjects: 74

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 74
Study: 11235215

Group type: EXPERIMENTAL
Intervention: Terazosin (TE)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Tamsulosin (TA)
Number of subjects: 38
Study: 9018184

Group type: EXPERIMENTAL
Intervention: Oral methylprednisolone (2 mg/kg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (2 mg/kg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups (oral and i.v.)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patients discharged home
Number of subjects: 49
Study: 8475622

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for symptomatic patients with stenosis of at least 70%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for symptomatic patients with stenosis less than 30%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for patients with intermediate amounts of stenosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy for asymptomatic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of aspirin for asymptomatic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound as a screening procedure
Number of subjects: 0
Study: 3530595

Group type: EXPERIMENTAL
Intervention: U-40 insulin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: U-100 insulin
Number of subjects: 15
Study: 31903800

Group type: EXPERIMENTAL
Intervention: 5 hours of speech and language telerehabilitation by videoconference per week over four consecutive weeks together with usual care
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 62
Study: 29773079

Group type: EXPERIMENTAL
Intervention: Linagliptin (5 mg once daily for 12 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo (for 12 weeks)
Number of subjects: 43
Study: 28230008

Group type: EXPERIMENTAL
Intervention: TACE + argon-helium cryoablation
Number of subjects: 120

Group type: COMPARATOR
Intervention: TACE
Number of subjects: 120
Study: 24830514

Group type: EXPERIMENTAL
Intervention: RV 2D strain
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Segmental strain analysis
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: RV 2D strain by multiplane assessment
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Triplane assessment of the RV
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2D strain of 18 segments
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2D strain of 9 segments of the RV free wall
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2D strain of 3 segments in four-chamber view
Number of subjects: 118
Study: 23844470

Group type: EXPERIMENTAL
Intervention: Male medical students
Number of subjects: 507

Group type: COMPARATOR
Intervention: Overall multivariate test for gender
Number of subjects: 507
Study: 20202800

Group type: EXPERIMENTAL
Intervention: Drug Attitude Inventory (DAI) assessment
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: PANSS-positive score
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Sexual side effects
Number of subjects: 228
Study: 18375253

Group type: EXPERIMENTAL
Intervention: Rosiglitazone added to metformin (RM)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Metformin (M)
Number of subjects: 56
Study: 16470423

Group type: EXPERIMENTAL
Intervention: Ibuprofen (1 week postoperatively)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Ibuprofen (2 weeks postoperatively)
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Ibuprofen (combined treatment)
Number of subjects: 142

Group type: COMPARATOR
Intervention: No treatment (Control group)
Number of subjects: 142
Study: 12351281

Group type: EXPERIMENTAL
Intervention: mexiletine 600 mg/d
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: gabapentin 1200 mg/d
Number of subjects: 75

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 75
Study: 9833192

Group type: EXPERIMENTAL
Intervention: Imipenem/Cilastatin
Number of subjects: 154

Group type: COMPARATOR
Intervention: Alternative regimens
Number of subjects: 154
Study: 7865998

Group type: EXPERIMENTAL
Intervention: Danyihewei granule (DYHW)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Rongshisan (RSS)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 2702922

Group type: EXPERIMENTAL
Intervention: Screening tests for depressive disorders
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening tests for anxiety disorders
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-depressed comparison group (including subjects with remitted disorder)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-depressed comparison group (excluding subjects with remitted disorder)
Number of subjects: 0
Study: 781795

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate mouthrinse
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31610437

Group type: EXPERIMENTAL
Intervention: Short film featuring a young individual with personal experience of depression and suicidality (n=81)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Thematically unrelated control film (n=77)
Number of subjects: 158
Study: 30475165

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (given for four days)
Number of subjects: 1149

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 1149
Study: 28586856

Group type: EXPERIMENTAL
Intervention: Enhanced primary care
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Enhanced primary care plus coaching
Number of subjects: 721

Group type: COMPARATOR
Intervention: Control (Enhanced primary care)
Number of subjects: 721
Study: 26590240

Group type: EXPERIMENTAL
Intervention: Strategies‐To‐Enhance‐Practice (STEPs) intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control ASPs
Number of subjects: 20
Study: 23237154

Group type: EXPERIMENTAL
Intervention: Population-based recall (Pop-recall)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Practice-based recall (PCP-recall)
Number of subjects: 195
Study: 21767688

Group type: EXPERIMENTAL
Intervention: Distant healing from self-reported healers (healing condition)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control condition)
Number of subjects: 60
Study: 19095873

Group type: EXPERIMENTAL
Intervention: Modified intertendinous approach
Number of subjects: 109

Group type: COMPARATOR
Intervention: Classic posterior approach
Number of subjects: 109
Study: 17066108

Group type: EXPERIMENTAL
Intervention: Less stigmatising attitude towards people with psychiatric illness
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Age, levels of education, and belief in causation of mental illness
Number of subjects: 84
Study: 15503070

Group type: EXPERIMENTAL
Intervention: Post-fracture care needs assessment
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Changes in ability to walk, form of housing, mortality, and level of care and help
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Formal and informal support
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Financial support and institutional care
Number of subjects: 332
Study: 10983860

Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for 3 days
Number of subjects: 225

Group type: COMPARATOR
Intervention: Pivampicillin 700 mg twice daily for 10 days
Number of subjects: 225
Study: 8814030

Group type: EXPERIMENTAL
Intervention: Controlled continuous orthodontic force of 50 cN applied to the maxillary right premolar
Number of subjects: 56

Group type: COMPARATOR
Intervention: Contralateral premolar (control)
Number of subjects: 56
Study: 1593357

Group type: EXPERIMENTAL
Intervention: Early feeding (hypocaloric enteral nutrition on postnatal days 3 to 5)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Late feeding (enteral nutrition on postnatal days 10 to 14)
Number of subjects: 27
Study: 3882106

Group type: EXPERIMENTAL
Intervention: Early mobilisation (fifth day)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Late mobilisation (tenth day)
Number of subjects: 742
Study: 30481229

Group type: EXPERIMENTAL
Intervention: Women with 4 children
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Women with ≥5 children
Number of subjects: 1135

Group type: EXPERIMENTAL
Intervention: Increment of one birth in women
Number of subjects: 1135

Group type: COMPARATOR
Intervention: Men
Number of subjects: 1135
Study: 27162127

Group type: EXPERIMENTAL
Intervention: Supervised exercise training programme
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 86
Study: 26187490

Group type: EXPERIMENTAL
Intervention: Xpert MTB/RIF
Number of subjects: 4656

Group type: COMPARATOR
Intervention: Sputum microscopy
Number of subjects: 4656
Study: 24101769

Group type: EXPERIMENTAL
Intervention: Maternal hair cortisol during the second and third trimester
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Child hair cortisol levels at year 1 and 3
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Repeated measures of child hair cortisol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High levels of hair cortisol
Number of subjects: 100
Study: 20498136

Group type: EXPERIMENTAL
Intervention: 1 mg of lorazepam
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 19112786

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of pre-oxygenated HBOC-201
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dry occlusion (without HBOC-201 infusion)
Number of subjects: 0
Study: 16404407

Group type: EXPERIMENTAL
Intervention: sibutramine 10 mg once daily plus behavioral therapy
Number of subjects: 46

Group type: COMPARATOR
Intervention: behavioral therapy alone (control)
Number of subjects: 46
Study: 12699797

Group type: EXPERIMENTAL
Intervention: Frozen section of the endocervical margin of the cone specimen
Number of subjects: 203

Group type: COMPARATOR
Intervention: No frozen section of the endocervical margin of the cone specimen
Number of subjects: 203
Study: 10805062

Group type: EXPERIMENTAL
Intervention: Emedastine (4 mg q.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emedastine (2 mg b.i.d.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg q.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8916563

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1497864

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 6507132

Group type: EXPERIMENTAL
Intervention: Metrizamide
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 60
Study: 4028596

Group type: EXPERIMENTAL
Intervention: Tc‐99m pyrophosphate (PYP) with 3.4 mg of stannous chloride
Number of subjects: 34

Group type: COMPARATOR
Intervention: Tc‐99m methylene diphosphonate (MDP) with 3.4 mg of stannous chloride
Number of subjects: 34

Group type: COMPARATOR
Intervention: Tc‐99m methylene diphosphonate (MDP) with 1.0 mg of stannous chloride
Number of subjects: 34
Study: 29741196

Group type: EXPERIMENTAL
Intervention: 1.5-hour physical activity module including a one-hour exercise tutorial combined with a 30-minute practical counselling session
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (2015)
Number of subjects: 161
Study: 26619359

Group type: EXPERIMENTAL
Intervention: Pertuzumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trastuzumab
Number of subjects: 0
Study: 24611852

Group type: EXPERIMENTAL
Intervention: Mindfulness Training for Smokers (MTS)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Usual care therapy (Controls)
Number of subjects: 196
Study: 23772084

Group type: EXPERIMENTAL
Intervention: Infliximab (IFX)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20533631

Group type: EXPERIMENTAL
Intervention: Centripetal open‐sandwich technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Centripetal closed‐sandwich technique
Number of subjects: 30
Study: 25160920

Group type: EXPERIMENTAL
Intervention: Intoxicated with alcohol
Number of subjects: 417

Group type: COMPARATOR
Intervention: Not intoxicated with alcohol
Number of subjects: 417
Study: 16888045

Group type: EXPERIMENTAL
Intervention: Transient cooling protocol
Number of subjects: 88
Study: 14639675

Group type: EXPERIMENTAL
Intervention: Pramipexole (1.5 mg t.i.d.)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pergolide (1.5 mg t.i.d.)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11049977

Group type: EXPERIMENTAL
Intervention: Unexpanded CD34-selected PBPCs
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Expanded PBPCs
Number of subjects: 121

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 121